Literature DB >> 3316241

Association of macrophages detected with monoclonal antibody 25 F 9 with progression and pathobiological classification of gastric carcinoma.

G Heidl1, P Davaris, G Zwadlo, M S Jagoda, S Düchting, E Bierhoff, T Grüter, V Krieg, C Sorg.   

Abstract

Using monoclonal antibody 25 F 9, which reacts with a determinant of mature macrophages, the inflammatory infiltrate of 66 gastric carcinomas was evaluated using a counting grid. The ratio tumor cells/macrophages was determined for every tumor. For a threshold value of 5, carcinomas with a better prognosis, such as the intestinal type according to Lauré, the expanding type according to Ming and the differentiated carcinomas according to the WHO had a significantly smaller relative content of 25 F 9-positive macrophages (a minimum of P less than 0.05) than the diffuse type, infiltrative type, and undifferentiated carcinomas. Furthermore, the relative macrophage content tended to increase with the stage of carcinomas spread (P less than 0.1). The results suggested that 25 F 9-positive macrophages in gastric carcinoma are of greater significance in tumor spread than in any defensive reaction against the tumor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316241     DOI: 10.1007/BF00390867

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  55 in total

1.  Gastric carcinoma. A pathobiological classification.

Authors:  S C Ming
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

2.  Detection and quantitation of macrophage infiltration into primary human tumors with the use of cell-surface markers.

Authors:  G W Wood; K A Gollahon
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

3.  [Immunohistologic studies of macrophage infiltration and proliferation rate in breast cancer and in mastopathy].

Authors:  E Vollmer; E Grundmann; H Nienhaus; W Mellin; G Zwadlo
Journal:  Verh Dtsch Ges Pathol       Date:  1985

4.  Monoclonal anti-human monocyte antibodies OKM1 and OKM5 possess distinctive tissue distributions including differential reactivity with vascular endothelium.

Authors:  D M Knowles; B Tolidjian; C Marboe; V D'Agati; M Grimes; L Chess
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

5.  Stromal reaction around tumor and metastasis and prognosis after curative gastrectomy for carcinoma of the stomach.

Authors:  K Inokuchi; S Inutsuka; M Furusawa; K Soejima; T Ikeda
Journal:  Cancer       Date:  1967-11       Impact factor: 6.860

Review 6.  What's new in macrophage-tumor cell interaction?

Authors:  L Kopper; K Lapis
Journal:  Pathol Res Pract       Date:  1985-05       Impact factor: 3.250

7.  Surface membrane heterogeneity among human mononuclear phagocytes.

Authors:  A Biondi; T H Rossing; J Bennett; R F Todd
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

8.  Tumor-associated macrophages stimulate the proliferation of murine tumor cells surviving treatment with the oncolytic cyclophosphamide analogue Asta Z-7557: in vivo implications.

Authors:  R Evans; T Duffy; R T Cullen
Journal:  Int J Cancer       Date:  1984-12-15       Impact factor: 7.396

9.  Antigens on human monocytes identified by monoclonal antibodies.

Authors:  R F Todd; L M Nadler; S F Schlossman
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

10.  Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma.

Authors:  M M Ribeiro; J A Sarmento; M A Sobrinho Simões; J Bastos
Journal:  Cancer       Date:  1981-02-15       Impact factor: 6.860

View more
  8 in total

1.  In situ detection of basic fibroblast growth factor by highly specific antibodies.

Authors:  K Schulze-Osthoff; W Risau; E Vollmer; C Sorg
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

Review 2.  Alleviating oxidative stress in cancer immunotherapy: a role for histamine?

Authors:  K Hellstrand; M Brune; C Dahlgren; M Hansson; S Hermodsson; P Lindnér; U H Mellqvist; P Naredi
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.064

Review 3.  Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies.

Authors:  Claire Lewis; Craig Murdoch
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

4.  Macrophages in melanocytic naevi.

Authors:  E B Bröcker; C Reckenfeld; H Hamm; D J Ruiter; C Sorg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

5.  Macrophages and multicellular tumor spheroids in co-culture: a three-dimensional model to study tumor-host interactions. Evidence for macrophage-mediated tumor cell proliferation and migration.

Authors:  S Hauptmann; G Zwadlo-Klarwasser; M Jansen; B Klosterhalfen; C J Kirkpatrick
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

6.  Gastric carcinoma with lymphoid stroma. Analysis using mucin histochemistry and immunohistochemistry.

Authors:  N Lertprasertsuke; Y Tsutsumi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Squamous cell carcinoma: infiltrating monocyte/macrophage subpopulations express functional mature phenotype.

Authors:  C Neuchrist; M Grasl; O Scheiner; H Lassmann; K Ehrenberger; D Kraft
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

8.  Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer.

Authors:  D A C Deans; S J Wigmore; H Gilmour; S Paterson-Brown; J A Ross; K C H Fearon
Journal:  Br J Cancer       Date:  2006-11-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.